Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Levacetylmethadol is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. Levacetylmethadol was withdrawn from use in the... Levacetylmethadol was withdrawn from use in the European Union due to its high risk of QT interval prolongation.
- Mechanism
- Curator reviewed
Opiate receptors (Mu, Kappa, Delta) are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Levomethadyl acetate effectively opens calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist), resulting in hyperpolarization and reduced neuronal excitability.
- Primary indication
- For the treatment and management of opiate dependence.Curator reviewed
- Formula / weight
- C23H31NO2 · 353.4977 g/mol (avg)
- Also known as
- 1-alpha-Acetylmethadol · LAAM · Levo-alpha-acetylmethadol · Levo-methadyl acetate · Levomethadyl
Resolves to
XBMIVRRWGCYBTQ-AVRDEDQJSA-NSMILESCC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Levacetylmethadol, and which of those have an active Phase 3 trial?